about
Recurrent Microvirgula aerodenitrificans bacteremia.Managing malaria in tuberculosis patients on fluoroquinolone-containing regimens: assessing the risk of QT prolongation.Occupational Tuberculosis despite Minimal Nosocomial Contact in a Health Care Worker Undergoing Treatment with a Tumor Necrosis Factor Inhibitor.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis.Real-world use of fidaxomicin in a large UK tertiary hospital: How effective is it for treating recurrent disease?Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens [Correspondence]Moxifloxacin for tuberculosis
P50
Q34280955-6B4E9DDB-365F-42F2-B127-948D6F1D323DQ37975064-E6FB5E85-6578-4D49-8F1D-10DC75BF2FE8Q48176634-CC1CAE40-4796-4BC7-86A7-B3F74318CD17Q52625145-4F205DB1-FC1D-4663-A92D-9DE0C9479ED0Q54205303-025781D1-3AC4-42F4-AABF-23FAD26F9EF7Q54215456-181E294D-209B-4D6B-8374-2F631A04D14DQ61995485-EC057E7F-B264-4014-B3F6-7710FA9CE07DQ95453140-EEE0B165-270C-4E30-918E-FDEC340FD5D8
P50
description
researcher ORCID ID = 0000-0002-3161-6612
@en
name
Michael E Murphy
@ast
Michael E Murphy
@en
Michael E Murphy
@nl
type
label
Michael E Murphy
@ast
Michael E Murphy
@en
Michael E Murphy
@nl
prefLabel
Michael E Murphy
@ast
Michael E Murphy
@en
Michael E Murphy
@nl
P31
P496
0000-0002-3161-6612